Concepedia

Robert Ernst Portmann

RE

Statistics

Publications

6

Citations

390

H-Index

6

Active since

1971

Affiliations

Novartis (Switzerland)(Current)

Robert Ernst Portmann is an author at Novartis (Switzerland) specializing in medicinal chemistry, drug discovery, and heterocyclic compounds.

Publications per year

1971–2007

6

Publications

6

Discovery of a Potent and Selective Protein Kinase CK2 Inhibitor by High-Throughput Docking

Eric Vangrevelinghe, Kaspar Zimmermann, Joseph Schoepfer et al. · Journal of Medicinal Chemistry · 2003 · 215 citations

, , +17

Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone:  A Potent, Orally Bioavailable Human CB<sub>1</sub>/CB<sub>2</sub>Dual Agonist with Antihyperalgesic Properties and Restricted Central Nervous System Penetration

Edward K. Dziadulewicz, Stuart Bevan, Christopher T. Brain et al. · Journal of Medicinal Chemistry · 2007 · 96 citations · Full text

, , +16

Notiz zur Synthese Eines Optisch Aktiven Ace‐Hemmers mit Amino‐oxo‐benzazepin‐1‐alkansäure‐Struktur mittels enantiokonvergierender kristallisationsinduzierter Racemat‐Trennung

Stephen Boyer, Rolland A. Pfund, Robert Ernst Portmann et al. · Helvetica Chimica Acta · 1988 · 36 citations

, , +10

Synthese von 2‐Thia‐6‐aza‐adamantan und Derivaten

Christian Ganter, Robert Ernst Portmann · Helvetica Chimica Acta · 1971 · 19 citations

, , +9

Heterotricyclodecane XIV. 2‐Oxa‐6‐aza‐adamantan und Derivate

Robert Ernst Portmann, Camille Ganter · Helvetica Chimica Acta · 1973 · 14 citations

, , +9

1–5 of 6